Skip to main content
Fig. 1 | BMC Urology

Fig. 1

From: Clinical characteristics and treatment outcomes of kidney transplant recipients with de novo urothelial carcinoma: thirty years of experience from a single center

Fig. 1

The survival of the patients in different group

A.The PFS time between CsA group and Tac group in T1 and lower stage of UTUC;

B. The PFS time between Rap group and control group in T2 and higher stage of UTUC;

C. The OS time between different sites in T1 and lower stage;

D. The RFS time between different sites in T1 and lower stage;

E. The OS time between different sites in T2 and higher stage

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us